EE9800144A - Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon - Google Patents

Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon

Info

Publication number
EE9800144A
EE9800144A EE9800144A EE9800144A EE9800144A EE 9800144 A EE9800144 A EE 9800144A EE 9800144 A EE9800144 A EE 9800144A EE 9800144 A EE9800144 A EE 9800144A EE 9800144 A EE9800144 A EE 9800144A
Authority
EE
Estonia
Prior art keywords
dione
oxime derivatives
het
indole
ring
Prior art date
Application number
EE9800144A
Other languages
English (en)
Estonian (et)
Inventor
W�tjen Frank
Drejer J�rgen
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of EE9800144A publication Critical patent/EE9800144A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9800144A 1996-10-01 1997-10-01 Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon EE9800144A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK106996 1996-10-01
DK127796 1996-11-13
PCT/DK1997/000418 WO1998014447A1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives

Publications (1)

Publication Number Publication Date
EE9800144A true EE9800144A (et) 1998-10-15

Family

ID=26065167

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800144A EE9800144A (et) 1996-10-01 1997-10-01 Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon

Country Status (28)

Country Link
US (3) USRE38200E1 (cs)
EP (1) EP0869958B1 (cs)
JP (1) JP3319762B2 (cs)
KR (1) KR100492052B1 (cs)
CN (1) CN1093859C (cs)
AT (1) ATE286052T1 (cs)
AU (1) AU716435B2 (cs)
BG (1) BG63874B1 (cs)
BR (1) BR9706765A (cs)
CA (1) CA2238410C (cs)
CZ (1) CZ297938B6 (cs)
DE (1) DE69732090T2 (cs)
DK (1) DK0869958T3 (cs)
EE (1) EE9800144A (cs)
ES (1) ES2235253T3 (cs)
HU (1) HU225145B1 (cs)
IL (1) IL124563A (cs)
IS (1) IS2123B (cs)
NO (1) NO310722B1 (cs)
NZ (1) NZ330456A (cs)
PL (1) PL193041B1 (cs)
PT (1) PT869958E (cs)
RU (1) RU2190612C2 (cs)
SI (1) SI0869958T1 (cs)
SK (1) SK282729B6 (cs)
TR (1) TR199800956T1 (cs)
UA (1) UA54403C2 (cs)
WO (1) WO1998014447A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
CA2326576A1 (en) 1998-03-31 1999-10-07 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives for therapeutic use
ATE420636T1 (de) 1999-05-19 2009-01-15 Painceptor Pharma Corp Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen
DE60120925T2 (de) * 2000-01-24 2006-11-09 Neurosearch A/S Isatinderivate mit neurotropen aktivität
IT1318636B1 (it) * 2000-07-21 2003-08-27 Roberto Pellicciari Derivati dell'acido 2- o 3- tenoico ad attivita' antagonista deirecettori del glutammato.
US20040063742A1 (en) * 2001-02-15 2004-04-01 Dan Peters Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
EP1406902B1 (en) 2001-07-13 2005-10-19 Pharmacia & Upjohn Company LLC Hexahydroazepino[4,5-g]indoles and indolines as 5-ht receptor ligands
CN1296372C (zh) * 2002-08-22 2007-01-24 神经研究公司 制备吲哚-2,3-二酮-3-肟衍生物的对映异构体的方法
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
KR20080070749A (ko) * 2005-11-23 2008-07-30 페인셉터 파마 코포레이션 개폐 이온 통로를 조절하기 위한 조성물 및 방법
CA2652307A1 (en) * 2006-04-10 2007-10-18 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2007115403A1 (en) * 2006-04-10 2007-10-18 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2008031831A2 (en) * 2006-09-12 2008-03-20 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20080108622A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
US20080108603A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
WO2010104324A2 (ko) * 2009-03-10 2010-09-16 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도
CN102653538A (zh) * 2011-03-04 2012-09-05 爱斯医药科技(南京)有限公司 Spd-502的制备方法
BR112017023038A2 (pt) 2015-04-29 2018-07-03 Janssen Pharmaceutica Nv imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa
MA41988B1 (fr) 2015-04-29 2021-03-31 Janssen Pharmaceutica Nv Azabenzimidazoles et leur utilisation comme modulateurs du recepteur ampa
AU2016255424B2 (en) 2015-04-29 2020-10-08 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators
WO2016176463A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Indolone compounds and their use as ampa receptor modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use
CA2076948C (en) * 1991-08-28 2002-04-16 Frank Watjen Isatineoxime derivatives, their preparation and use
MY128102A (en) * 1993-02-17 2007-01-31 Chugai Pharmaceutical Co Ltd Indolin-2-one-derivatives
US5721230A (en) 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
CA2161783C (en) 1993-05-13 2006-08-15 Frank Watjen Ampa antagonists and a method of treatment therewith
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
JP3164372B2 (ja) * 1994-09-14 2001-05-08 ノイロサーチ アクティーゼルスカブ 融合インドール及びキノキサリン誘導体、その製造および使用
NZ293265A (en) * 1994-09-14 1998-01-26 Neurosearch As 5-aryl-isoquinoline-2-one-3-acyloxime derivatives fused with a n-heterocyclic ring
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму

Also Published As

Publication number Publication date
AU4376897A (en) 1998-04-24
CZ160698A3 (cs) 1998-10-14
PL193041B1 (pl) 2007-01-31
HUP9901630A3 (en) 2001-11-28
PL327073A1 (en) 1998-11-23
IS4748A (is) 1998-05-18
JP2000501432A (ja) 2000-02-08
IS2123B (is) 2006-07-14
HK1017682A1 (en) 1999-11-26
UA54403C2 (uk) 2003-03-17
EP0869958A1 (en) 1998-10-14
HU225145B1 (en) 2006-07-28
HUP9901630A2 (hu) 1999-08-30
SI0869958T1 (en) 2005-06-30
USRE38200E1 (en) 2003-07-22
NO982466D0 (no) 1998-05-29
DE69732090D1 (de) 2005-02-03
PT869958E (pt) 2005-05-31
US6693111B1 (en) 2004-02-17
NO982466L (no) 1998-07-31
AU716435B2 (en) 2000-02-24
BG102489A (en) 1999-04-30
US6124285A (en) 2000-09-26
SK67698A3 (en) 1998-11-04
CA2238410C (en) 2007-06-12
CN1207100A (zh) 1999-02-03
IL124563A0 (en) 1998-12-06
ATE286052T1 (de) 2005-01-15
NZ330456A (en) 1998-11-25
DK0869958T3 (da) 2005-04-18
EP0869958B1 (en) 2004-12-29
MX9804365A (es) 1998-10-31
CZ297938B6 (cs) 2007-05-02
BR9706765A (pt) 1999-09-14
JP3319762B2 (ja) 2002-09-03
ES2235253T3 (es) 2005-07-01
RU2190612C2 (ru) 2002-10-10
KR100492052B1 (ko) 2005-09-30
BG63874B1 (bg) 2003-04-30
CA2238410A1 (en) 1998-04-09
NO310722B1 (no) 2001-08-20
DE69732090T2 (de) 2005-12-29
WO1998014447A1 (en) 1998-04-09
CN1093859C (zh) 2002-11-06
KR19990071823A (ko) 1999-09-27
SK282729B6 (sk) 2002-11-06
IL124563A (en) 2005-05-17
TR199800956T1 (xx) 1998-12-21

Similar Documents

Publication Publication Date Title
EE9800144A (et) Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EA200100970A1 (ru) Аминопроизводные как ингибиторы протеазы
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
YU64092A (sh) Fluoralkoksibenzamino derivati heterocikličnih jedinjenja koja sadrže azot
FI954609A0 (fi) 1-amidinofenyyli-pyrrolidoneja, -piperidinoneja ja -atsetinoneja verihiutaleiden kasaantumisen inhibiittoreina
ES2162466T3 (es) Derivados de 1,2,4-triazolo(4,3-b)pirido(3,2-d)piridazina y composiciones farmaceuticas que los contienen.
PT807633E (pt) Novas pirimidin-4-onas substituidas em 2,3, e fundidas com heteroarilo em (5,6)
AR005597A1 (es) Derivados de benzoxazina , composiciones farmaceuticas para el tratamiento de infecciones bacterianas, y metodo para la preparacion de dichos derivados.
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
NO305287B1 (no) AMPA antagonister
IT1317048B1 (it) Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie
IL91648A (en) Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
EA199700205A1 (ru) Прокинетические оксадиазолы
FR2671349B1 (fr) Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
DE60310928D1 (de) Par-2-aktivierendes peptidderivat und pharmazeutische zusammensetzung, in der dieses verwendet wird
TW367328B (en) Benzofuro[3,2-b]pyridine derivatives, process for the preparation thereof and pharmaceutical composition containing the same
EE03355B1 (et) Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamine ja kasutamine
AR019390A1 (es) Derivados de acidos sulfonilaminofosfinicos y sulfonilaminofosfonicos, procedimiento para su preparacion, compuestos intermediarios, medicamentos, procedimiento para su preparacion y empleo de dichos derivados para la preparacion de un medicamento.
HUP9801810A2 (hu) Imidazo[1,5-a]piridin-csoporttal helyettesített szerin-proteáz inhibitorok, ezek előállítása és ezeket tartalmazó gyógyszerkészítmények
AR036554A1 (es) Coniosulfuros y sus derivados, procedimiento para su preparacion y su utilizacion como medicamentos
ES455436A1 (es) Procedimiento de preparacion de acidos tienotienilcarbonife-nilalcanoicos.
EA200200721A1 (ru) Производные диазепинкарбоксамида, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и их применение